14.3 Signal Transduction & Intracellular Communication

The Four-Step Signaling Model

Cells in a multicellular organism must coordinate proliferation, differentiation, metabolism, and death. They do so by signal transduction — converting an extracellular cue (a ligand such as a hormone, growth factor, neurotransmitter, or cytokine) into an intracellular response (altered gene expression, enzyme activity, ion flux, or cytoskeletal rearrangement). The PA-CAT Bulletin of Information, rev. 20240815 groups Intracellular Communication within its Signal Transduction content area, and the canonical model has four stages:

1. Signal — a signaling molecule (ligand) is released and travels to a target cell.
2. Reception — the ligand binds a specific receptor (cell-surface or intracellular).
3. Transduction — the receptor activates an intracellular relay, often a cascade of proteins and small-molecule second messengers.
4. Response — a downstream effector (kinase, transcription factor, ion channel) alters cell behavior.

A defining feature of transduction is amplification: each activated receptor can generate many second-messenger molecules, each of which activates many downstream enzymes, so a single ligand–receptor binding event can yield thousands of final-effect molecules. This is why hormones act at nanomolar or lower concentrations.

Modes of Cell Signaling

Signaling is classified by the distance the signal travels from its source.

A variant, synaptic signaling, is sometimes listed separately: an electrical signal triggers neurotransmitter release across a narrow synaptic cleft — it is a specialized, extremely fast paracrine event.

PA-CAT items often ask you to classify a scenario: insulin acting on the liver is endocrine; a neuron releasing acetylcholine onto a muscle fiber is paracrine/synaptic; a T cell presenting antigen to a T-cell receptor is juxtacrine.

Second Messengers

Once a receptor is engaged, the signal must cross the plasma membrane (for surface receptors) or be propagated inside the cell. Second messengers are small, diffusible intracellular molecules that relay and amplify the signal. The four PA-CAT-relevant second messengers are cyclic AMP (cAMP), Ca²⁺, inositol 1,4,5-trisphosphate (IP3), and diacylglycerol (DAG).

cAMP and Protein Kinase A

The classic pathway: a Gs protein–coupled receptor activates adenylyl cyclase, which converts ATP to 3',5'-cyclic AMP (cAMP). cAMP binds the regulatory subunits of protein kinase A (PKA), releasing the catalytic subunits, which phosphorylate targets such as CREB (a transcription factor), glycogen synthase, and phosphorylase kinase. cAMP is degraded by phosphodiesterases (PDEs), terminating the signal — caffeine and theophylline inhibit PDEs, prolonging cAMP signaling.

IP3, DAG, and Ca²⁺

A different Gq-coupled receptor activates phospholipase C (PLC), which cleaves the membrane phospholipid PIP2 into two second messengers: IP3 (water-soluble, diffuses into the cytosol) and DAG (lipophilic, stays in the membrane).

• IP3 binds the IP3 receptor on the endoplasmic reticulum, opening a Ca²⁺ channel and releasing stored Ca²⁺ into the cytosol.
• DAG (with the released Ca²⁺) activates protein kinase C (PKC), which phosphorylates its own set of targets.
• Cytosolic Ca²⁺ also binds calmodulin; the Ca²⁺–calmodulin complex activates Ca²⁺/calmodulin-dependent protein kinases (CaMKs) and myosin light-chain kinase.

Cross-Talk and Termination

Signaling pathways are not linear pipelines; they cross-talk. PKA and PKC can both phosphorylate overlapping substrates; Ca²⁺ can modulate adenylyl cyclase; MAPK cascades (section 14.5) receive inputs from multiple receptor types. Termination is equally important: GTP hydrolysis on Gα, phosphodiesterase degradation of cAMP, Ca²⁺-ATPases that pump Ca²⁺ back into the ER or out of the cell, and receptor desensitization via β-arrestin binding all restore basal state. Loss of termination underlies diseases such as cholera (Gαs locked active → uncontrolled cAMP → secretory diarrhea).

Amplification Explained

Consider the Gs → cAMP → PKA pathway. One ligand-bound receptor activates multiple Gs proteins (each an enzyme for adenylyl cyclase) during its lifetime; each adenylyl cyclase makes many cAMP molecules; each PKA holoenzyme contains two catalytic subunits that each phosphorylate many substrates. The result is an enzymatic cascade with amplification factors of 10–100 at each tier, producing a final response that can be 10⁴–10⁶-fold larger than the input signal — the molecular basis for hormone sensitivity at nanomolar concentrations.

Why This Matters on the PA-CAT

This section is the conceptual bridge between the RNA/transcription machinery (sections 14.1–14.2) and the specific receptor classes in sections 14.4–14.5. Expect items that test: (1) classification of signaling modes (autocrine/paracrine/endocrine/juxtacrine), (2) which second messenger activates PKA (cAMP) versus PKC (DAG + Ca²⁺), (3) the source of IP3 and DAG (PIP2 cleavage by PLC), (4) where IP3 releases Ca²⁺ from (the ER), and (5) the principle of amplification in a cascade. Memorize the table above — it is a high-yield PA-CAT comparison.